biopath holdings shares were down 49 at 39 cents after the company priced a public offering of 35 million shares together with common stock purchase warrants at 60 cents a share and accompanying common stock purchase warrant the stock hit its 52week low of 37 cents earlier in the session and closed wednesdays session 23 lower the stock is down 89 in the past 12 months the biotechnology expects to see proceeds of 21 million the stock purchase warrants are exercisable immediately and will expire five years from the date of issuance the offering is expected to close on or about monday